Table 2. Tumor Characteristics .
RNA (n = 145) | Acquire 22G (n = 43) | ProCore 22G (n = 45) | ProCore 20G (n = 57) | p-value |
NCCN Stage | ||||
Operable, n (%) | 2 (5) | 6 (13) | 3 (5) | 0.759 |
Borderline resectable, n (%) | 4 (9) | 6 (13) | 7 (12) | |
Locally advanced, n (%) | 15 (35) | 14 (31) | 19 (33) | |
Metastatic, n (%) | 19 (44) | 18 (18) | 26 (46) | |
Tumour location | ||||
Head, n (%) | 18 (42) | 30 (67) | 33 (58) | 0.426 |
Neck, n (%) | 5 (12) | 5 (11) | 2 (4) | |
Body, n (%) | 8 (19) | 4 (9) | 10 (18) | |
Tail, n (%) | 3 (7) | 2 (4) | 4 (7) | |
Uncinate, n (%) | 5 (12) | 2 (4) | 3 (5) | |
Distal, n (%) | 1 (2) | 1 (2) | 1 (2) | |
Other, n (%) | 0 (0) | 0 (0) | 2 (4) | |
Presence of onsite Cytology, n (%) | 5 (12) | 41 (91) | 12 (21) | <0.001 |